Ian W. Flinn, MD, Ph.D.

Dr. Flinn is board certified in Medical Oncology and Hematology. He has been with Tennessee Oncology since 2006 and has been practicing medicine since 1993. He is currently the Director of Hematologic Malignancies Research at the Sarah Cannon Research Institute and the Clinical Director of the Sarah Cannon Blood and Marrow Transplant Program in Nashville, TN.

Dr. Flinn comes to us from the Johns Hopkins University School of Medicine in Baltimore, Maryland where he was an Associate Professor of Oncology and he served as the Assistant Director of Clinical Research in The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Prior to receiving his medical degree from Johns Hopkins University School of Medicine, Dr. Flinn completed a Bachelor of Arts in Economics at Georgetown University in Washington, DC. He carried out his clinical fellowships in Oncology and Hematology at Johns Hopkins University School of Medicine and his residency and internships in Internal Medicine at the University of Michigan Medical Center in Ann Arbor, Michigan.

Dr. Flinn's research interest is in developing new therapies for patients with hematologic malignancies. This research includes new chemotherapeutic, immunologic and transplant approaches to these diseases.

Dr. Flinn specializes in leukemia, lymphoma, multiple myeloma, and blood and marrow transplantation. He has published widely in this area. He holds memberships in the American Society of Clinical Oncology, the American college of Physicians, the American Society of Hematology, and the American Society for Blood and Marrow Transplantation.

Dr. Flinn sees patients at the Tennessee Oncology in the Sarah Cannon Blood and Marrow Transplant Clinic at Centennial Medical Center.